About
Chai Discovery raises $130M at a $1.3B valuation to scale its Chai-2 platform, which massively improves AI-designed antibody success rates and speeds drug development.
About
Chai Discovery raises $130M at a $1.3B valuation to scale its Chai-2 platform, which massively improves AI-designed antibody success rates and speeds drug development.